News

All Releases
View Summary Sophiris Bio Announces Changes to Board of Directors
Jul 12, 2013
PDF 12.8 KB Add to Briefcase
View Summary Sophiris Bio Reports First Quarter Financial Results and Recent Key Operational Highlights
Apr 30, 2013
PDF 16.1 KB Add to Briefcase
View Summary Correction - Sophiris Bio Inc. Files Registration Statement for Proposed Initial U.S. Public Offering on the NASDAQ
Feb 15, 2013
PDF 11.5 KB Add to Briefcase
View Summary Sophiris Bio Reports Fourth Quarter and Year-End 2012 Financial Results and Key Operational Highlights
Feb 13, 2013
PDF 15.9 KB Add to Briefcase
View Summary Sophiris Bio Appoints a New Director to the Board
Nov 30, 2012
PDF 10.9 KB Add to Briefcase
View Summary Sophiris Bio to Present at 11th Annual BIO Investor Forum
Oct 2, 2012
PDF 10.6 KB Add to Briefcase
View Summary Sophiris' Drug for Benign Prostatic Hyperplasia was Well Tolerated Using the Preferred Transrectal Route of Administration
Aug 31, 2012
PDF 13.3 KB Add to Briefcase
View Summary Protox is Now "Sophiris Bio"
Apr 2, 2012
PDF 9.1 KB Add to Briefcase
View Summary Protox Completes All Cohort Dosing in Transrectal Study
Mar 28, 2012
PDF 9.1 KB Add to Briefcase
View Summary Warburg Pincus Invests in Additional Funding in Protox
Mar 28, 2012
PDF 9.2 KB Add to Briefcase
View Summary Protox to Present at Healthcare Conference
Mar 22, 2012
PDF 8.7 KB Add to Briefcase
Showing 61-71 of 71 Page: 1 2 3 4  Previous 20
Add to Briefcase = add release to Briefcase